QuidelOrtho (QDEL) Income towards Parent Company (2021 - 2024)
QuidelOrtho (QDEL) reported Income towards Parent Company of -$1.7 billion for Q1 2024, down 3595.9% on a YoY basis from $48.8 million in Q2 2023, and down 222.8% sequentially from -$528.5 million in Q4 2023.
QuidelOrtho (QDEL) Income towards Parent Company (2021 - 2024) Analysis & Trends
QuidelOrtho (QDEL) has 4 years of Income towards Parent Company data on file, last reported at -$1.7 billion in Q1 2024.
- For the quarter ending Q1 2024, Income towards Parent Company fell 3595.9% year-over-year to -$1.7 billion; the trailing twelve-month figure through Dec 2024 stood at -$1.7 billion (down 212.68% YoY), and the FY2024 full-year result was -$2.1 billion, down 20216.83% from the prior year.
- Income towards Parent Company declined to -$1.7 billion in Q1 2024, from -$528.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $479.9 million in Q2 2022 to a low of -$1.7 billion in Q1 2024.
- A 4-year average of -$123.9 million and a median of $19.2 million in 2022 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company rose 1.05% in 2022 and plunged 3595.9% in 2024, its largest moves.
- Tracing QDEL's Income towards Parent Company over 4 years: stood at $215.7 million in 2021, then slumped by 91.1% to $19.2 million in 2022, then tumbled by 2852.6% to -$528.5 million in 2023, then sank by 222.8% to -$1.7 billion in 2024.
- Business Quant data shows QDEL's Income towards Parent Company at -$1.7 billion in Q1 2024, -$528.5 million in Q4 2023, and -$12.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | QuidelOrtho | 1.15 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -528.50 Mn |
| Oct 1, 2023 | -12.70 Mn |
| Jul 2, 2023 | -53.20 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |